MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. HOOD
9. DFTX
10. IBM

Go back to MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
(NASDAQ: MGTX) Delayed: 11.48 +0.16 (1.41%)
Previous Close $11.32    52 Week High $ 
Open $11.48    52 Week Low $ 
Day High $11.81    P/E N/A 
Day Low $11.18    EPS $ 
Volume 1,292,750       

(NASDAQ: MGTX) Delayed: 11.48 +0.16 (1.41%)
Previous Close $11.32    52 Week High $ 
Open $11.48    52 Week Low $ 
Day High $11.81    P/E N/A 
Day Low $11.18    EPS $ 
Volume 1,292,750